The Scientist - Home

Analysts warn that good marketing and sound financing are as key to survival for new ventures as top-notch science ST. LOUIS--After 20 years of vigorous scientific growth, neuroscience has vacated the biotechnology umbrella to emerge as a promising industry of its own. With an annual United States market of $4.4 billion in sales, neuropharmaceuticals is one area of biotechnology in which investors are always looking for a great deal. About two dozen startups are pursuing new technologies for d

They acknowledge a laxness in following and monitoring research safety guidelines, which could pose a serious risk to some investigators Last spring, when eight students at the University of Pennsylvania's veterinary school went to the school's rural New Bolton Center to castrate some lambs, they considered it to be business as usual. Likewise for the parents and teachers of a nearby preschool class that visited and petted the sheep. What neither group knew was that just a month before, Jorge

Michael T. White, former general manager of Brunswick Biotechnetics in San Diego, has joined the Research Institute of Scripps Clinic, La Jolla, as an associate to the industrial liaison officer. The new position was created to facilitate the management and protection of the intellectual properties of the Scripps Research Institute. White received a Ph.D. in botanical sciences and genetics in 1971 from the University of California, Los Angeles. He holds an MBA in marketing, earned in 1980, als

(The Scientist, Vol:5, #2, pg. 20, January 21, 1991) (Copyright, The Scientist, Inc.) ---------- Eli Lilly Helps Women Chemists Travel Women undergraduate, graduate, and postdoctoral chemists who wish to present their research results at meetings can apply for travel grants provided by Eli Lilly & co. and administered by the American Chemical Society's Women Chemists Committee. Money is intended for travel to, registration at, and accommodations for scientific meetings within the continental

Starting salaries for new geology graduates, especially those entering environmental fields or the domestic oil and gas industries, are rising, according to a recently compiled survey by the Alexandria, Va.-based American Geological Institute. AGI's latest annual survey of starting salaries for inexperienced graduates, released this month, projected that geologists with master's and doctoral degrees beginning work in 1990 would reap the highest increases over the starting salaries paid to their

In its 173rd annual business meeting last month, the New York Academy of Sciences (NYAS) honored four scientists for their contributions to science and society. Vitali Goldanski, director of the Semonyov Institute of Chemical Physics of the USSR Academy of Sciences in Moscow, received the $2,000 NYAS Award for his work in chemical physics, nuclear physics, and chemistry and biophysics. The award also recognized Goldanski, the chairman of the Soviet Pugwash Group, for "his contributions to disa

Since the earliest days of the biotechnology endeavor, scientists have sought a practical way of co-opting the complex biological machinery that regulates DNA. From the moment they identified the intriguing enzymes that choreograph the dance of DNA replication, biotechnologists began developing ways to commander them; the swivelases and gyrases, forms of unwinding proteins that untwist the molecule; the nucleases, which snip it; the strands; the ligases, which tie these strands together; and ev

As Congress sends mixed signals on funding, USDA, NOAA, and EPA promise to go beyond their in-house staffs Efforts by three federal agencies to increase their use of extramural scientists could mean more funding for academic research, but only if Congress cooperates. The United States Department of Agriculture, the National Oceanographic and Atmospheric Administration, and the Environmental Protection Agency plan to expand programs that give out money for extramural, peer-reviewed research. T

Laying It On With A Shovel Walking Away From Trouble Feeling Insecure About National Security GAO: NASA Flunks Physical Molecular biologist David Baltimore, president of Rockefeller University and former director of the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology, returned to MIT last month for a "rededication" of the institute. Baltimore, who has taken heat from Congress for his role in defending a former colleague, immunologist Thereza Ima

CLOSE-UP -- J. Leslie Glick (The Scientist, Vol:5, #2, pg. 8, January 21, 1991) (Copyright, The Scientist, Inc.) ---------- J. Leslie Glick, president and chief executive officer of Bionix Inc. of Potomac, Md., insists that he never really intended to start a neurospecialty company. "I essentially had decided to retire," recalls the 68-year-old biologist and biotech executive. "But there are only so many museums in Washington, and I wanted to do something that would benefit the

An agency report suggests merit review revisions that would simplify proposals, extend grant duration, and give staff more autonomy WASHINGTON--A report of an in-house panel that examined peer review at the National Science Foundation proposes drastic remedies for what it says is an overburdened and inefficient system of selecting and awarding grants. Its recommendations--longer-term grants, more autonomy for program officers and less reliance on outside reviewers, fewer categories of grants,

Dozens of research teams vie for a vast commercial market awaiting those who discover how to protect the body against itself BOSTON--A decade ago, disorders like Graves' disease, myasthenia gravis, and systemic lupus erythematosus--diseases in which the immune system attacks the body's own tissues--were mysteries that eluded reliable or effective treatment. Too little was known about how the immune system works and, consequently, why it goes awry in these diseases. But research during the past